Sotuvning operatsion marjasi: Immix (IMMX)

Immix Biopharma Inc. (IMMX) kompaniyasining korporativ logotipi

Immix Biopharma, Inc. (IMMX) og'ir gematologik saratonlarga qarshi kurashish uchun o'simta mikro muhitini normallashtiruvchi CAR-T NXC-201 ni ishlab chiqmoqda. Yakuniy operatsion marja salbiy tendentsiyani namoyish etmoqda, bunda 0.00 ushbu ko'rsatkichning joriy darajasini ifodalaydi. Innovatsion hujayraviy platforma narxlarni belgilash imkoniyati uchun potensial yaratadi, autoimmun patologiyalar terapiyasi bo'yicha ilmiy hamjamiyatning yuqori kutuvlari esa kompaniyaning texnologik maqomini tasdiqlaydi.

IMMX: Immix Biopharma Inc. Operatsion foyda normasi 04.07.2022 - 19.11.2026

Immix Biopharma Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (IMMX)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:IMMX, immixbio.com
Immix Biopharma asosiy tovari

CAR-T terapiyasi ishlab chiquvchisi Immix Biopharma, Inc. (IMMX) uchun operatsion marja qattiq o'simtali o'smalarga qarshi dori vositalarini ishlab chiqish xarajatlarini boshqarish samaradorligini B2B sektori daromadlariga nisbatan aks ettiradi. Operatsion marjaning vaqtlar ketma-ketligidagi tahlili biznesning foizlar va soliqlardan oldingi foyda keltirish qobiliyatini baholash imkonini beradi, bu esa aktivning fundamental barqarorligini va tanlangan strategik yo'nalishning aniqligini belgilaydi.

Immix Biopharma, Inc. kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IBRX|IMCR - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi JANX (Janux Pharma)|Operatsion foyda koeffitsiyenti RCUS|Operatsion marja ZYME (Zymeworks)|Operatsion foyda normasi TNGX|iovance.com - Operatsion marja|Sotuvning operatsion rentabelligi Immatics Biotechnologies|Xencor, Inc. (XNCR) - Operatsion rentabellik|Compass Therapeutics - Operatsion foyda normasi|REPL (replimune.com) - Operatsion marja|Operatsion marja Lyell|Operatsion rentabellik Innate Pharma (IPHA)|PYXS: Operatsion foyda marjasi|Compugen - Sotuvning operatsion marjasi|IO Biotech, Inc. (IOBT) - Sotuvning operatsion rentabelligi|STRO - Operatsion rentabellik|MiNK Therapeutics (INKT) - Sotuvning operatsion marjasi|HOWL: Operatsion marja|ALXO (ALX Oncology Holdings) - Operatsion rentabellik|Sotuvning operatsion marjasi CUE|PDS Biotechnology Corporation (PDSB) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Sonnet BioTherapeutics Holdings Inc. (SONN)|Operatsion marja MAIA Biotechnology Inc (MAIA)|Operatsion rentabellik Liminatus Pharma LIMN|Operatsion foyda normasi LVTX|NXTC: Sotuvning operatsion marjasi|leaptx.com - Operatsion foyda koeffitsiyenti|INTS: Operatsion marja|Sensei Biotherapeutics Inc - Operatsion foyda normasi|Sotuvning operatsion marjasi TOVX|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja